Physician profile

John W Funnell

Optometrist · Manhattan Beach, CA

NPI 1023045796

$1,047.04

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$24.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Coopervision INC. $389.85 2019-2024 Misight Contact Lens
Bausch & Lomb, A Division of Bausch Health US, LLC $194.50 2019-2020
Abb Con-Cise Optical Group LLC $118.51 2019-2021
Johnson & Johnson Surgical Vision, INC. $99.93 2019
Optovue, INC. $92.81 2019
Johnson & Johnson Vision Care, INC. $76.81 2019
Oyster Point Pharma, INC. $25.73 2022
Alcon Vision LLC $23.00 2019
Visioneering Technologies, INC. $15.21 2020
Optos, INC. $10.69 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John W Funnell

$1,047.04

in general payments reported 2019-2025

Years
2019-2024
Top company
Coopervision INC.

https://glasscript.com/doctor/562880/john-w-funnell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.